Lilly's Zepbound tops Wegovy for weight loss in head-to-head trial
Eli Lilly said on Wednesday patients taking its obesity drug Zepbound lost 47% more weight than those who were given Novo ...
FDA tags Wegovy with new warning for gastrointestinal reactions
Participants in Wegovy clinical trials were more likely to report “severe gastrointestinal adverse reactions,” the FDA's ...
STAT11h
Pharmalittle: We’re reading about a Zepbound-Wegovy faceoff, compounders slamming the FDA, and more
Eli Lilly said its weight loss drug Zepbound led to 47% greater weight reduction than rival medicine Wegovy, made by Novo ...
The Root on MSN1d
5 Inconvenient Truths About Ozempic, Wegovy and Other Semaglutides, According to Doctors
As the Biden administration is proposing drugs like Ozempic and Wegovy be covered by Medicare and Medicaid, the debate about ...